Results 31 to 40 of about 1,668 (161)

Identification of Levothyroxine Antichagasic Activity through Computer-Aided Drug Repurposing [PDF]

open access: yes, 2014
Cruzipain (Cz) is the major cysteine protease of the protozoan Trypanosoma cruzi, etiological agent of Chagas disease. A conformation-independent classifier capable of identifying Cz inhibitors was derived from a 163-compound dataset and later applied in
Alberca, Lucas Nicolás   +5 more
core   +8 more sources

Protease inhibitors targeting coronavirus and filovirus entry. [PDF]

open access: yes, 2015
In order to gain entry into cells, diverse viruses, including Ebola virus, SARS-coronavirus and the emerging MERS-coronavirus, depend on activation of their envelope glycoproteins by host cell proteases.
Agudelo, Juliet   +10 more
core   +1 more source

In vitro and in silico studies of polycondensed diazine systems as anti-parasitic agents [PDF]

open access: yes, 2012
Parasitic diseases caused by protozoarian agents are still relevant today more than ever. Recently, we synthesized several polycondensed diazine derivatives by means 1,3-dipolar cycloaddition reactions. A broad selection of these compounds were submitted
Almerico, A.   +3 more
core   +1 more source

Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors. [PDF]

open access: yes, 2011
Matrix metalloproteinases are zinc-containing enzymes capable of degrading all components of the extracellular matrix. Owing to their role in human disease, matrix metalloproteinase have been the subject of extensive study.
de Oliveira, César AF   +2 more
core   +1 more source

Cruzain structures: apocruzain and cruzain bound to S-methyl thiomethanesulfonate and implications for drug design

open access: yesActa Crystallographica Section F Structural Biology Communications, 2019
Chagas disease, which is caused by Trypanosoma cruzi, affects more than six million people worldwide. Cruzain is the major cysteine protease involved in the survival of this parasite. Here, the expression, purification and crystallization of this enzyme are reported.
Elany, Barbosa da Silva   +4 more
openaire   +3 more sources

On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors

open access: yesRSC Medicinal Chemistry, 2020
Aldehyde peptide like compounds display a bivalent reactive profile and improved antichagasic potency.
Vinicius Bonatto   +12 more
openaire   +3 more sources

The substrate specificity of cruzipain 2, a cysteine protease isoform from Trypanosoma cruzi [PDF]

open access: yes, 2006
Papain-like cysteine proteases are important for the survival of the flagellated protozoa Trypanosoma cruzi, the causative agent of Chagas' Disease.
Judice, Wagner AS   +5 more
core   +1 more source

Structure-Based and Molecular Modeling Studies for the Discovery of Cyclic Imides as Reversible Cruzain Inhibitors With Potent Anti-Trypanosoma cruzi Activity

open access: yesFrontiers in Chemistry, 2019
Chagas disease causes ~10,000 deaths each year, mainly in Latin America, where it is endemic. The currently available chemotherapeutic agents are ineffective in the chronic stage of the disease, and the lack of pharmaceutical innovation for Chagas ...
Rafael A. A. Ferreira   +10 more
doaj   +1 more source

Current and future chemotherapy for Chagas disease [PDF]

open access: yes, 2015
Luís Gaspar is thankful to FCT for funding (scholarship reference: SFRH/BD/81604/2011). The research leading to these results has received funding from the European Community’s Seventh Framework Programme under grant agreement No.602773 (Project KINDRED)
Cordeiro-da-Silva, Anabela   +10 more
core   +1 more source

Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay. [PDF]

open access: yes, 2011
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged as the causal agent of an endemic atypical pneumonia, infecting thousands of people worldwide.
Agudelo, Juliet   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy